Article
Polymorphisms in the MTHFR gene are associated with breast cancer risk and prognosis in a Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 May 2015
Lu Qing, Jiang Ke, Li Qiong, Ji Ya-Jie, Chen Wei-Li, Xue Xiao-Hong
Abstract excerpt
Breast cancer is the most common cancer affecting women in China and the world. Folate supplementation is proven to be effective in reducing the risk of breast cancer or improving its prognosis. Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme involved in folate metabolism and DNA synthesis. This study aims to examine whether single nucleotide polymorphisms (SNP) in the MTHFR gene are associated...
Topics
- Adult
- Aged
- Breast Neoplasms
- China
- Female
- Folic Acid
- Genetic Association Studies
- Genotype
- Haplotypes
- Humans
- Methylenetetrahydrofolate Reductase (NADPH2)
